CUTANEON is a Germany-based R&D company specializing in cosmeceuticals, nutraceuticals, and dermatological drugs, with a primary focus on dermatology, skin aging, hair growth, and pigmentation control. Founded by Professor Ralf Paus, the company is actively seeking investors to support its R&D projects and the commercialization of groundbreaking products. CUTANEON differentiates itself by conducting product development research directly in human skin or hair follicles, utilizing state-of-the-art in silico modeling for the identification of patentable actives. The company strategically collaborates with Monasterium Laboratory, a leading research services provider in the field. Additionally, CUTANEON is set to operate its own research laboratory in the new “Biocube” from IV/2023. Emphasizing ecological sustainability, natural compounds, product safety, and long-term skin/hair benefits, the company is committed to developing innovative, eco-friendly products. CUTANEON also presents attractive investment opportunities, offering Seed and Series A investments, as well as Joint Ventures and Spinouts, serving as a foundation for its revolutionary portfolio.
There is no investment information
No recent news or press coverage available for CUTANEON.